Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1987 Mar;77(3):361–365. doi: 10.2105/ajph.77.3.361

AIDS screening, confidentiality, and the duty to warn.

L Gostin, W J Curran
PMCID: PMC1646908  PMID: 3544882

Full text

PDF
361

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Curran J. W., Morgan W. M., Hardy A. M., Jaffe H. W., Darrow W. W., Dowdle W. R. The epidemiology of AIDS: current status and future prospects. Science. 1985 Sep 27;229(4720):1352–1357. doi: 10.1126/science.2994217. [DOI] [PubMed] [Google Scholar]
  2. Francis D. P., Jaffe H. W., Fultz P. N., Getchell J. P., McDougal J. S., Feorino P. M. The natural history of infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III. Ann Intern Med. 1985 Nov;103(5):719–722. doi: 10.7326/0003-4819-103-5-719. [DOI] [PubMed] [Google Scholar]
  3. Francis D. P., Petricciani J. C. The prospects for and pathways toward a vaccine for AIDS. N Engl J Med. 1985 Dec 19;313(25):1586–1590. doi: 10.1056/NEJM198512193132506. [DOI] [PubMed] [Google Scholar]
  4. Jaffe H. W., Hardy A. M., Morgan W. M., Darrow W. W. The acquired immunodeficiency syndrome in gay men. Ann Intern Med. 1985 Nov;103(5):662–664. doi: 10.7326/0003-4819-103-5-662. [DOI] [PubMed] [Google Scholar]
  5. Kelley P. W., Redfield R. R., Ward D. L., Burke D. S., Miller R. N. Prevalence and incidence of HTLV-III infection in a prison. JAMA. 1986 Oct 24;256(16):2198–2199. [PubMed] [Google Scholar]
  6. Landesman S. H., Ginzburg H. M., Weiss S. H. The AIDS epidemic. N Engl J Med. 1985 Feb 21;312(8):521–525. doi: 10.1056/nejm198502213120829. [DOI] [PubMed] [Google Scholar]
  7. Osterholm M. T., Bowman R. J., Chopek M. W., McCullough J. J., Korlath J. A., Polesky H. F. Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis? N Engl J Med. 1985 May 2;312(18):1185–1189. doi: 10.1056/NEJM198505023121810. [DOI] [PubMed] [Google Scholar]
  8. Petricciani J. C. Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificity. Ann Intern Med. 1985 Nov;103(5):726–729. doi: 10.7326/0003-4819-103-5-726. [DOI] [PubMed] [Google Scholar]
  9. Robert-Guroff M., Weiss S. H., Giron J. A., Jennings A. M., Ginzburg H. M., Margolis I. B., Blattner W. A., Gallo R. C. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA. 1986 Jun 13;255(22):3133–3137. [PubMed] [Google Scholar]
  10. Sarngadharan M. G., Popovic M., Bruch L., Schüpbach J., Gallo R. C. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984 May 4;224(4648):506–508. doi: 10.1126/science.6324345. [DOI] [PubMed] [Google Scholar]
  11. Schorr J. B., Berkowitz A., Cumming P. D., Katz A. J., Sandler S. G. Prevalence of HTLV-III antibody in American blood donors. N Engl J Med. 1985 Aug 8;313(6):384–385. doi: 10.1056/NEJM198508083130610. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES